AppTec and Boehringer Ingelheim’s first year of partnering is providing enhanced capabilities and a smooth transition to large-scale manufacturing for clients, according to the companies. Last spring, AppTec announced that Boehringer Ingelheim had become a preferred partner for its commercial cell culture production, including supply of Phase III material and CMC submission to meet specific customer needs. Through this collaboration, AppTec has non-exclusive access to Boehringer’s comprehe...